Karel Allegaert1,2,3, Isabel Spriet4,5. 1. Intensive Care and Department of Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands. karel.allegaert@uzleuven.be. 2. Department of Development and Regeneration, KU Leuven, Leuven, Belgium. karel.allegaert@uzleuven.be. 3. Neonatal Intensive Care Unit, University Hospital, Herestraat 49, 3000, Leuven, Belgium. karel.allegaert@uzleuven.be. 4. Pharmacy Department, University Hospitals Leuven, Leuven, Belgium. 5. Department of Pharmacological and Pharmaceutical Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium.
Authors: M A Turner; J C Duncan; U Shah; T Metsvaht; H Varendi; G Nellis; I Lutsar; S Yakkundi; J C McElnay; H Pandya; H Mulla; P Vaconsin; T Storme; A Rieutord; A J Nunn Journal: Adv Drug Deliv Rev Date: 2013-11-13 Impact factor: 15.470
Authors: Georgi Nellis; Tuuli Metsvaht; Heili Varendi; Jana Lass; Jennifer Duncan; Anthony J Nunn; Mark A Turner; Irja Lutsar Journal: Paediatr Drugs Date: 2016-06 Impact factor: 3.022
Authors: H C Pandya; H Mulla; M Hubbard; R L Cordell; P S Monks; S Yakkundi; J C McElnay; A J Nunn; M A Turner Journal: Eur J Pediatr Date: 2016-03-21 Impact factor: 3.183